Ingro Finanz AG is an investment holding company specialized in late stage venture investments.
Ingro Finance AG is a privately held Swiss company focusing on the purchase,administration and divestment of all types of participations. The investment portfolio of thecompany comprises amongst others participations in various life science companies.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 12, 2009
NovImmune
|
Series Unknown | $54.80M | Biotechnology | — |
|
Sep 24, 2007
Ganymed Pharmaceuticals
|
Series C | €33.70M | Biopharma | — |
Ingro Finanz AG has had 1 exits. Ingro Finanz AG most notable exits include Ganymed Pharmaceuticals
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Oct 28, 2016 | Ganymed Pharmaceuticals | M&A | Biopharma | Detail |